07/01/2025
3:31 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
06/16/2025
8:10 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
8:40 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
4:35 PM | DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:35 PM | Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:36 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:34 PM | Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:34 PM | Honore Tage (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
05/21/2025
8:23 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:06 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for VNDA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/25/2025
3:31 PM | Vanda Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2025
3:33 PM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
03/17/2025
8:15 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
4:53 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:44 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:45 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:30 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:13 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:38 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:04 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
7:21 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:43 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
3:46 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
12:40 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
7:22 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:45 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:07 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
7:00 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
4:00 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:10 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:47 AM | Vanda Pharmaceuticals (Filer)
| Form 8-A12B/A | |
08/08/2024
6:29 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
08/01/2024
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:05 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
4:21 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
4:24 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
